Unlike rival CDK 4/6 inhibitor abemaciclib, patients don't need to be lymph-node positive to receive ribociclib after surgery ...

and two years of chemotherapy tablets to reduce the risk of the cancer coming back. I am also still processing everything I have been through which can be emotionally difficult. I recently needed ...

Doctors say restrictions on the number of tablets patients receive ... Wright and other cancer specialists call ondansetron a cornerstone treatment because of its relative safety, effectiveness ...

A new study has identified a potential breakthrough treatment to combat aggressive forms of prostate cancer. Researcher Luke ...

The cancer had spread to some of the fat cells around my colon, all removed now." She revealed that the next steps of her treatment involved three months of chemotherapy, with a combination of ...

Kate says her focus is on "staying cancer free" after finishing chemotherapy. Her road to a full recovery remains "long", a ...

Today’s positive decision follows the manufacturer, Daiichi Sankyo, offering a fair price for the treatment that the National Institute for Health and Care Excellence (NICE) determined to be ...

Ad hoc announcement pursuant to Art. 53 LR Broad indication in HR+/HER2- stage II and III early breast cancer (EBC) at high risk of recurrence approximately doubles population eligible for CDK4/6 ...

The two most commonly used DAAs are combination drugs: Mavyret (glecaprevir /pibrentasvir). Mavyret was first approved by the ...

Cancer patients can ward off waves of vomiting after treatment with a relatively cheap anti-nausea pill, but some are running into coverage limits. Doctors say restrictions on the number of tablets ...